))
Copay Accumulator Plan Designs: What Life Sciences Manufacturers Need to Know Heading into 2024
Manage episode 389685468 series 2950783
Contenido proporcionado por Mercalis. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Mercalis o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss the latest updates via a roundtable discussion. We welcomed to the studio our colleague Michael Harris, Mercalis’ VP of Patient Support Services Strategy. He was joined by Carl Schmid, the Executive Director at the HIV + Hepatitis Policy Institute and Bill Sarraille, a Partner with the Sidley law firm in Washington, D.C. This information will be very helpful to life sciences decision makers who are planning for 2024 and beyond.
31 episodios
Compartir
